ALKS Alkermes plc

NASDAQ
$46.85

Alkermes plc (ALKS) Earnings News

Earnings press releases, previews and reviews for Alkermes plc (ALKS), newest first. Our most recent is review: Alkermes Beats Its Own Guidance, but Lybalvi Pricing Dilution and Takeda's Orexin Launch Cloud a Stronger Quarter.